Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mitsuya

Showing results (11-20 of 343) with videos related to

Pageof 35
Sort By:
Current Drug Targets. Infectious Disorders|November 29, 2002
4'-C-substituted-2'-deoxynucleosides: a family of antiretroviral agents which are potent against drug-resistant HIV variantsH Ohrui, H Mitsuya
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1986
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosidesH Mitsuya, S Broder
Shikai Tenbo = Dental Outlook|January 1, 1978
[Partial denture base harmless to the teeth and periodontal tissue]R Mori, H Mitsuya
Current Topics in Microbiology and Immunology|January 1, 1985
Human T-cell leukemia/lymphoma viruses (HTLV): a unique family of pathogenic retrovirusesH Mitsuya, S Broder
Nature|February 4, 1987
Strategies for antiviral therapy in AIDSH Mitsuya, S Broder
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 29, 1998
[Anti-HIV drugs and drug delivery system]K Obaru, H Mitsuya
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 1, 1993
[CD4-derivatives therapy of HIV carriers]T Mizukami, H Mitsuya
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 26, 2002
[Severe combined immunodeficiency disease and similar combined immunodeficiency disease]H Nakata, H Mitsuya
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 1, 1993
[Reverse transcriptase inhibitors as anti-HIV agents]T Shirasaka, H Mitsuya
Biochemistry|February 4, 1997
Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assayT Ueno, H Mitsuya
Pageof 35

Showing results (11-20 of 343) with videos related to

Sort By:
Pageof 35
Current Drug Targets. Infectious Disorders|November 29, 2002
4'-C-substituted-2'-deoxynucleosides: a family of antiretroviral agents which are potent against drug-resistant HIV variantsH Ohrui, H Mitsuya
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1986
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosidesH Mitsuya, S Broder
Shikai Tenbo = Dental Outlook|January 1, 1978
[Partial denture base harmless to the teeth and periodontal tissue]R Mori, H Mitsuya
Current Topics in Microbiology and Immunology|January 1, 1985
Human T-cell leukemia/lymphoma viruses (HTLV): a unique family of pathogenic retrovirusesH Mitsuya, S Broder
Nature|February 4, 1987
Strategies for antiviral therapy in AIDSH Mitsuya, S Broder
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 29, 1998
[Anti-HIV drugs and drug delivery system]K Obaru, H Mitsuya
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 1, 1993
[CD4-derivatives therapy of HIV carriers]T Mizukami, H Mitsuya
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 26, 2002
[Severe combined immunodeficiency disease and similar combined immunodeficiency disease]H Nakata, H Mitsuya
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 1, 1993
[Reverse transcriptase inhibitors as anti-HIV agents]T Shirasaka, H Mitsuya
Biochemistry|February 4, 1997
Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assayT Ueno, H Mitsuya
Pageof 35